<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Retinal Vein Occlusion - Blood Vessel Blockage Guide | Vision Health Portal</title>
    <meta name="description"
        content="Comprehensive guide to retinal vein occlusion: blocked retinal vein causing sudden vision loss, retinal hemorrhages and swelling, branch (BRVO) vs central (CRVO), anti-VEGF injections treatment.">
    <link rel="stylesheet" href="../style.css">
    <link rel="stylesheet" href="disease-style.css">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css">
</head>

<body>
    <header>
        <a href="../index.html" class="logo">
            <i class="fas fa-eye"></i> VisionHealth
        </a>
        <nav>
            <ul>
                <li><a href="../index.html">Home</a></li>
                <li><a href="../tests/index.html">Vision Tests</a></li>
                <li><a href="../innovations.html">Innovations</a></li>
            </ul>
        </nav>
    </header>

    <div class="disease-hero">
        <h1>Retinal Vein Occlusion</h1>
        <p>Blocked Retinal Vein Causing Vision Loss</p>
        <span class="category"><i class="fas fa-tag"></i> Retinal Vascular Disease</span>
    </div>

    <div class="disease-content-wrapper">
        <aside class="toc">
            <h3>Contents</h3>
            <ul>
                <li><a href="#overview">Overview</a></li>
                <li><a href="#types">Types</a></li>
                <li><a href="#causes">Causes & Risk Factors</a></li>
                <li><a href="#symptoms">Symptoms</a></li>
                <li><a href="#diagnosis">Diagnosis</a></li>
                <li><a href="#complications">Complications</a></li>
                <li><a href="#treatment">Treatment</a></li>
                <li><a href="#prognosis">Prognosis</a></li>
                <li><a href="#prevention">Prevention</a></li>
                <li><a href="#when-to-see">When to See a Doctor</a></li>
            </ul>
        </aside>

        <main class="disease-content">
            <section id="overview">
                <h2>What Is Retinal Vein Occlusion?</h2>
                <p>Retinal vein occlusion (RVO) is a blockage of one of the veins that drain blood from the retina,
                    causing blood and fluid to back up into the retinal tissue. This leads to retinal hemorrhages,
                    swelling (macular edema), and ischemia (oxygen deprivation), resulting in sudden, painless vision
                    loss. RVO is often described as an "eye stroke" and is the second most common retinal vascular
                    disease after diabetic retinopathy. It typically affects one eye and occurs more commonly in older
                    adults with cardiovascular risk factors like hypertension, diabetes, and glaucoma.</p>

                <p>There are two main types: branch retinal vein occlusion (BRVO), in which a tributary branch vein is
                    blocked affecting only part of the retina, and central retinal vein occlusion (CRVO), in which the
                    main central retinal vein is blocked affecting the entire retina (more severe). Treatment focuses on
                    managing complications—primarily macular edema—with anti-VEGF injections, corticosteroid injections,
                    or laser therapy. Visual outcomes depend on the type, severity, and how quickly treatment is
                    initiated. Some cases recover well, while others result in permanent vision impairment, especially
                    if complicated by ischemia or neovascular glaucoma.</p>

                <div class="key-facts">
                    <h3><i class="fas fa-info-circle"></i> Key Facts About Retinal Vein Occlusion</h3>
                    <ul>
                        <li><strong>Blocked retinal vein:</strong> Blood/fluid backs up into retina.</li>
                        <li><strong>Sudden painless vision loss:</strong> Blurred or decreased vision, often upon
                            waking.</li>
                        <li><strong>Two types: BRVO (branch) and CRVO (central)</strong></li>
                        <li><strong>Risk factors: hypertension, diabetes, glaucoma, age >50</strong></li>
                        <li><strong>Retinal hemorrhages and swelling on exam</strong></li>
                        <li><strong>Treatment: anti-VEGF injections</strong> for macular edema.</li>
                        <li><strong>Complications: chronic edema, neovascularization, glaucoma</strong></li>
                        <li><strong>Second most common retinal vascular disease</strong></li>
                    </ul>
                </div>

                <p>Understanding RVO emphasizes the importance of managing cardiovascular risk factors and seeking
                    prompt evaluation for sudden vision changes.</p>
            </section>

            <section id="types">
                <h2>Types of Retinal Vein Occlusion</h2>

                <h3>Branch Retinal Vein Occlusion (BRVO)</h3>
                <ul>
                    <li><strong>Most common type</strong> (~75-80% of RVOs)</li>
                    <li>Blockage of tributary branch vein (not main central vein)</li>
                    <li>Affects only part of retina (quadrant or sector)</li>
                    <li><strong>Vision impact:</strong>
                        <ul>
                            <li>If macula involved: significant vision loss</li>
                            <li>If peripheral retina only: may be asymptomatic or mild</li>
                        </ul>
                    </li>
                    <li>Generally better prognosis than CRVO</li>
                </ul>

                <h3>Central Retinal Vein Occlusion (CRVO)</h3>
                <ul>
                    <li>Blockage of main central retinal vein (at or behind optic nerve)</li>
                    <li>Affects entire retina</li>
                    <li><strong>More severe</strong> than BRVO</li>
                    <li>Two subtypes:
                        <ul>
                            <li><strong>Non-ischemic (perfused) CRVO:</strong> Better prognosis; retina still has blood
                                flow</li>
                            <li><strong>Ischemic CRVO:</strong> Severe; large areas of retina with no blood flow; worse
                                outcomes, higher risk of complications (neovascular glaucoma)</li>
                        </ul>
                    </li>
                </ul>

                <h3>Hemi-Retinal Vein Occlusion</h3>
                <ul>
                    <li>Occlusion at optic nerve affecting half the retina</li>
                    <li>Behaves similarly to CRVO</li>
                </ul>
            </section>

            <section id="causes">
                <h2>Causes and Risk Factors</h2>

                <h3>Mechanism of Occlusion</h3>
                <ul>
                    <li>Retinal arteries and veins share common adventitial sheath at arteriovenous (AV) crossing points
                    </li>
                    <li>Arteriosclerotic, rigid artery compresses adjacent vein → turbulent flow → thrombus (clot) forms
                        → vein occlusion</li>
                    <li>Blood/fluid backs up → retinal hemorrhages, edema, ischemia</li>
                </ul>

                <h3>Major Risk Factors</h3>

                <h4>Hypertension (Most Important)</h4>
                <ul>
                    <li>Present in ~70% of RVO patients</li>
                    <li>Causes arteriosclerosis → compression of veins</li>
                </ul>

                <h4>Age</h4>
                <ul>
                    <li>Incidence increases with age; most common >50 years</li>
                    <li>Median age ~60-65</li>
                </ul>

                <h4>Diabetes Mellitus</h4>
                <ul>
                    <li>Vascular damage predisposes to occlusion</li>
                </ul>

                <h4>Glaucoma or Ocular Hypertension</h4>
                <ul>
                    <li>Elevated intraocular pressure compresses veins at optic nerve → CRVO risk</li>
                </ul>

                <h4>Hyperlipidemia</h4>
                <ul>
                    <li>Atherosclerosis</li>
                </ul>

                <h4>Hypercoagulable States (Blood Clotting Disorders)</h4>
                <ul>
                    <li>Factor V Leiden, protein C/S deficiency, antiphospholipid syndrome</li>
                    <li>More common in younger patients with RVO (<50 years)</li>
                </ul>

                <h4>Smoking</h4>
                <ul>
                    <li>Vascular risk factor</li>
                </ul>

                <h4>Other</h4>
                <ul>
                    <li>Obesity, sleep apnea, cardiovascular disease</li>
                </ul>
            </section>

            <section id="symptoms">
                <h2>Recognizing the Symptoms</h2>

                <div class="symptoms-grid">
                    <div class="symptom-card">
                        <h4><i class="fas fa-cloud"></i> Sudden Painless Vision Loss</h4>
                        <p>Blurred or decreased vision in one eye; often noticed upon waking (overnight occlusion).</p>
                    </div>

                    <div class="symptom-card">
                        <h4><i class="fas fa-circle-notch"></i> Central or Sectoral Blind Spot</h4>
                        <p>Depending on location of occlusion (central if macula involved, peripheral if branch).</p>
                    </div>

                    <div class="symptom-card">
                        <h4><i class="fas fa-wave-square"></i> Distorted Vision</h4>
                        <p>From macular edema.</p>
                    </div>

                    <div class="symptom-card">
                        <h4><i class="fas fa-eye-slash"></i> Visual Field Loss</h4>
                        <p>Peripheral vision loss if branch occlusion affects peripheral retina.</p>
                    </div>

                    <div class="symptom-card">
                        <h4><i class="fas fa-ban"></i> No Pain</h4>
                        <p>Painless (unlike acute angle-closure glaucoma).</p>
                    </div>

                    <div class="symptom-card">
                        <h4><i class="fas fa-exclamation-circle"></i> Severity Varies</h4>
                        <p>Mild blur to severe vision loss (counting fingers or worse).</p>
                    </div>
                </div>
            </section>

            <section id="diagnosis">
                <h2>Diagnosis</h2>

                <h3>Clinical Examination</h3>

                <h4>Dilated Fundus Examination - Diagnostic</h4>
                <ul>
                    <li><strong>Classic findings:</strong>
                        <ul>
                            <li><strong>Retinal hemorrhages:</strong> "Blood and thunder" appearance (CRVO);
                                flame-shaped and dot-blot hemorrhages scattered throughout affected retina</li>
                            <li><strong>Dilated, tortuous veins:</strong> Engorged retinal veins</li>
                            <li><strong>Retinal edema:</strong> Cloudy, swollen retina</li>
                            <li><strong>Optic disc swelling</strong> (especially CRVO)</li>
                            <li><strong>Cotton-wool spots:</strong> Ischemic areas</li>
                        </ul>
                    </li>
                    <li>Appearance classic for diagnosis</li>
                </ul>

                <h3>Optical Coherence Tomography (OCT)</h3>
                <ul>
                    <li>Cross-sectional retinal imaging</li>
                    <li><strong>Shows:</strong> Macular edema quantitatively; retinal thickness</li>
                    <li>Guides treatment and monitors response</li>
                </ul>

                <h3>Fluorescein Angiography (FA)</h3>
                <ul>
                    <li>Dye injected IV; retinal photographs taken</li>
                    <li><strong>Shows:</strong>
                        <ul>
                            <li>Areas of retinal ischemia (non-perfusion)</li>
                            <li>Leakage from damaged vessels</li>
                            <li>Neovascularization (abnormal new vessels)</li>
                        </ul>
                    </li>
                    <li>Distinguishes ischemic vs. non-ischemic CRVO</li>
                    <li>Guides laser treatment decisions</li>
                </ul>

                <h3>Systemic Workup</h3>
                <ul>
                    <li><strong>Blood pressure measurement</strong></li>
                    <li><strong>Fasting glucose, HbA1c</strong> (diabetes screening)</li>
                    <li><strong>Lipid panel</strong></li>
                    <li><strong>If young patient (<50) or bilateral RVO:</strong> Hypercoagulability workup (factor V
                                Leiden, protein C/S, anticardiolipin antibodies, etc.)</li>
                </ul>
            </section>

            <section id="complications">
                <h2>Complications</h2>

                <h3>Macular Edema (Most Common)</h3>
                <ul>
                    <li>Fluid accumulation in macula</li>
                    <li>Primary cause of vision loss in RVO</li>
                    <li>Treatable with anti-VEGF injections or steroids</li>
                </ul>

                <h3>Retinal Neovascularization</h3>
                <ul>
                    <li>Abnormal new blood vessels grow on retina in response to ischemia</li>
                    <li>Can cause vitreous hemorrhage, retinal detachment</li>
                </ul>

                <h3>Neovascular Glaucoma (Severe Complication)</h3>
                <ul>
                    <li>New vessels grow on iris/drainage angle (rubeosis iridis)</li>
                    <li>Block aqueous drainage → very high IOP</li>
                    <li>Painful; difficult to treat</li>
                    <li>More common with ischemic CRVO</li>
                    <li>Requires anti-VEGF injections, panretinal photocoagulation, glaucoma medications/surgery</li>
                </ul>

                <h3>Vitreous Hemorrhage</h3>
                <ul>
                    <li>From neovascularization</li>
                    <li>Sudden severe vision loss</li>
                </ul>
            </section>

            <section id="treatment">
                <h2>Treatment</h2>

                <h3>Treat Underlying Risk Factors</h3>
                <ul>
                    <li>Control hypertension, diabetes, hyperlipidemia</li>
                    <li>Optimize cardiovascular health</li>
                    <li>Reduce IOP if glaucoma/ocular hypertension</li>
                </ul>

                <h3>Observation (Some Cases)</h3>
                <ul>
                    <li>If normal vision, no macular edema, peripheral BRVO: may observe</li>
                    <li>Many BRVOs improve spontaneously over months</li>
                </ul>

                <h3>Anti-VEGF Injections (First-Line for Macular Edema)</h3>
                <ul>
                    <li><strong>Medications:</strong> Aflibercept (Eylea), ranibizumab (Lucentis), bevacizumab (Avastin
                        off-label)</li>
                    <li><strong>Mechanism:</strong> Block vascular endothelial growth factor (VEGF) → reduce vascular
                        leakage and edema</li>
                    <li><strong>Procedure:</strong> Intravitreal injection (into vitreous gel) in office</li>
                    <li><strong>Schedule:</strong> Monthly initially, then as-needed or extended interval based on
                        response</li>
                    <li><strong>Effectiveness:</strong> Very effective; most patients maintain or improve vision</li>
                    <li>Also prevents/treats neovascularization</li>
                </ul>

                <h3>Corticosteroid Injections or Implants</h3>
                <ul>
                    <li><strong>Triamcinolone injection</strong> (Triesence) or <strong>dexamethasone implant</strong>
                        (Ozurdex)</li>
                    <li>Reduce inflammation and edema</li>
                    <li>Longer-acting than anti-VEGF</li>
                    <li><strong>Side effects:</strong> IOP elevation, cataract progression</li>
                    <li>Used if anti-VEGF insufficient or as alternative</li>
                </ul>

                <h3>Laser Photocoagulation</h3>

                <h4>Focal/Grid Laser for Macular Edema (BRVO)</h4>
                <ul>
                    <li>Historically used; now mostly replaced by anti-VEGF</li>
                    <li>Can be adjunct in some cases</li>
                </ul>

                <h4>Panretinal Photocoagulation (PRP) for Ischemia/Neovascularization</h4>
                <ul>
                    <li>Scatter laser to ischemic peripheral retina</li>
                    <li>Reduces VEGF production, prevents/treats neovascularization</li>
                    <li>Indicated if ischemic CRVO with neovascularization or high risk</li>
                </ul>
            </section>

            <section id="prognosis">
                <h2>Prognosis and Outcomes</h2>

                <h3>Branch Retinal Vein Occlusion (BRVO)</h3>
                <ul>
                    <li><strong>Generally good prognosis</strong></li>
                    <li>With treatment (anti-VEGF), most maintain or improve vision</li>
                    <li>Some recover spontaneously over 6-12 months</li>
                    <li>Complications less common than CRVO</li>
                </ul>

                <h3>Central Retinal Vein Occlusion (CRVO)</h3>
                <ul>
                    <li><strong>More variable outcomes</strong></li>
                    <li><strong>Non-ischemic CRVO:</strong> Better prognosis; many improve with treatment</li>
                    <li><strong>Ischemic CRVO:</strong> Worse prognosis; higher risk of complications (neovascular
                        glaucoma); some have persistent severe vision loss despite treatment</li>
                    <li>~15-20% of non-ischemic can convert to ischemic</li>
                </ul>

                <h3>Factors Affecting Prognosis</h3>
                <ul>
                    <li>Initial visual acuity (better initial vision → better outcome)</li>
                    <li>Degree of ischemia</li>
                    <li>Promptness of treatment</li>
                    <li>Response to anti-VEGF</li>
                </ul>
            </section>

            <section id="prevention">
                <h2>Prevention</h2>

                <h3>Control Cardiovascular Risk Factors</h3>
                <ul>
                    <li><strong>Blood pressure:</strong> Keep well-controlled</li>
                    <li><strong>Diabetes:</strong> Optimize glucose control</li>
                    <li><strong>Cholesterol:</strong> Manage hyperlipidemia</li>
                    <li><strong>Smoking cessation</strong></li>
                    <li><strong>Healthy weight, exercise</strong></li>
                </ul>

                <h3>Regular Eye Exams</h3>
                <ul>
                    <li>Especially if risk factors present</li>
                    <li>Control glaucoma/ocular hypertension</li>
                </ul>
            </section>

            <section id="when-to-see">
                <h2>When to See a Doctor</h2>

                <h3>Emergency - Seek Immediate Care If:</h3>
                <ul>
                    <li><strong>Sudden painless vision loss or blurring in one eye</strong></li>
                    <li><strong>Sudden visual field defect</strong></li>
                    <li>See retina specialist or go to ER</li>
                </ul>

                <h3>Questions to Ask Your Doctor</h3>
                <ul>
                    <li>Do I have BRVO or CRVO?</li>
                    <li>Is it ischemic or non-ischemic?</li>
                    <li>Do I need anti-VEGF injections?</li>
                    <li>What is my prognosis for vision?</li>
                    <li>How often will I need follow-up?</li>
                    <li>What are my risks for complications?</li>
                    <li>Should I see a primary care doctor to check for underlying causes?</li>
                </ul>
            </section>

            <div class="alert-box info">
                <h4><i class="fas fa-lightbulb"></i> Bottom Line</h4>
                <p>Retinal vein occlusion is blockage of a retinal vein causing sudden, painless vision loss from
                    retinal hemorrhages and swelling. Branch RVO (BRVO) affects part of the retina and has a better
                    prognosis, while central RVO (CRVO) affects the entire retina and can be more severe, especially if
                    ischemic. Risk factors include hypertension, diabetes, glaucoma, and age >50. Diagnosis is made by
                    fundus exam showing characteristic "blood and thunder" hemorrhages and dilated veins, confirmed with
                    OCT and fluorescein angiography. The main complication is macular edema causing vision loss, treated
                    with anti-VEGF injections (Eylea, Lucentis, Avastin) which are highly effective. Severe
                    complications include neovascular glaucoma (from ischemic CRVO) requiring panretinal laser and
                    anti-VEGF. Visual outcomes depend on type and severity; many BRVO patients recover well with
                    treatment, while ischemic CRVO has guarded prognosis. If you experience sudden vision loss, see a
                    retina specialist immediately. Prevention focuses on controlling cardiovascular risk factors like
                    hypertension and diabetes.</p>
            </div>

            <div class="related-diseases">
                <h3>Related Eye Conditions</h3>
                <div class="related-links">
                    <a href="diabetic-retinopathy.html">Diabetic Retinopathy</a>
                    <a href="glaucoma.html">Glaucoma</a>
                    <a href="macular-degeneration.html">Macular Degeneration</a>
                    <a href="retinal-detachment.html">Retinal Detachment</a>
                </div>
            </div>
        </main>
    </div>

    <footer>
        <div class="footer-content">
            <p>&copy; 2025 Vision Health Portal. All rights reserved.</p>
            <p class="designer-credit">Designed by RITIK DHAGE</p>
            <p style="font-size: 0.85rem; margin-top: 1rem; opacity: 0.8;">
                <i class="fas fa-info-circle"></i> This information is for educational purposes only and is not a
                substitute for professional medical advice, diagnosis, or treatment.
            </p>
        </div>
    </footer>
</body>

</html>